Due to dense infiltration of lymphocytes in tumor stroma and high expression of programmed death ligand 1 (PD-L1) on tumor cells, immune checkpoint blockades (ICB), particularly through programmed cell death protein 1 (PD-1)/PD-L1 axis, are involved for the treatment of NPC patients [11]. Here, PDCD1 is linked to neoplasm.